Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Named Professor of Pediatrics at Harvard Medical School
Lori Laffel, M.D., M.P.H., Chief of Joslin’s clinical programs for Children, Adolescents and Young Adults, and Senior Investigator in the Section on Genetics and Epidemiology, has been promoted by Harvard Medical School to Professor of Pediatrics.
9-Oct-2014 12:00 PM EDT
Why are Asian Americans at higher risk of developing type 2 diabetes than Caucasian Americans, and prone to develop the disease at lower body weights? One part of this puzzle may lie in the transition from traditional high-fiber, low-fat Asian diets...
17-Sep-2014 1:00 PM EDT
George King, M.D., Chief Scientific Officer and Senior Vice President of Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, and Lloyd Paul Aiello, M.D., Ph.D., Director of the Beetham Eye Institute (BEI) and Professor of...
10-Sep-2014 2:00 PM EDT
In a comprehensive review of recent randomized clinical trials and observational studies of diabetes and nutrition, Joslin Diabetes Center and Harvard School of Public Health investigators have identified specific foods and dietary patterns that are...
28-Aug-2014 11:00 AM EDT
– In a letter to United States Senators Susan Collins (R-Me) and Jeanne Shaheen (D-NH), John L. Brooks III, President and CEO of Joslin Diabetes Center, expressed Joslin’s strong support for legislation sponsored by the two senators that would...
26-Aug-2014 10:00 AM EDT
Scientists at Joslin Diabetes Center now have created the first iPSCs that offer a human model of insulin resistance, a key driver of type 2 diabetes.
24-Jul-2014 1:00 PM EDT
– Edward Horton, M.D., Senior Investigator at Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, received the Master of the American College of Endocrinology (MACE) Award at the American Association of Clinical...
14-Jul-2014 10:00 AM EDT
When a pregnant mother is undernourished, her child is at a greater than average risk of developing obesity and type 2 diabetes, in part due to so-called ‘epigenetic’ effects.
10-Jul-2014 2:30 PM EDT
Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT
13-Nov-2013 1:00 PM EST
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT